原发性扩张型心肌病(DCM)是原因不明的心肌疾病。产生心肌坏死、变性及纤维化,心肌收缩力明显低下,引起心腔扩大。近年虽然药物治疗有了长足的进步,但仍然预后不良。作为DCM治疗方法的心脏移植手术,近数年在欧美急剧增加。1987年全世界一年超过2000例,5年生存率超过70%。心脏移植作为治疗方法确立的同时,尚存在脑死亡、确保供体、供体心脏的保存及输 Primary dilated cardiomyopathy (DCM) is an unexplained cardiomyopathy. Produce myocardial necrosis, degeneration and fibrosis, myocardial contractility was significantly lower, causing the heart chamber to expand. In recent years, although the medical treatment has made considerable progress, but still a poor prognosis. Cardiac transplantation as a treatment for DCM has dramatically increased in Europe and the United States in recent years. In 1987, there were more than 2000 cases a year in the world, and the 5-year survival rate exceeded 70%. While heart transplantation is being established as a treatment, there is still brain death that ensures donor and donor heart preservation and loss